Related Experiment Video
Updated: Aug 19, 2026

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
Published on: August 19, 2016
Streptococcal toxic shock syndrome by an iMLS resistant M type 77 Streptococcus pyogenes in the Netherlands
J Gooskens1, A J De Neeling, R J Willems
1Department of Medical Microbiology, Centre of Infectious Diseases, University Medical Centre of Leiden, Bilthoven, The Netherlands. j.gooskens@lumc.nl
Abstract:
An increasing number of group A streptococci (GAS) with constitutive or inducible resistance to macrolide-lincosamide-streptogramin B antibiotics (cMLS or iMLS phenotype) is observed in Europe, but MLS resistant GAS associated with streptococcal toxic shock syndrome (STSS) has not been reported. We describe a patient admitted with STSS caused by an iMLS resistant T28 M77 Streptococcus pyogenes carrying the ermA [subclass TR] gene. A 2-y retrospective analysis among 701 nationwide collected GAS strains revealed an incidence of 3.1% of this M type 77 GAS. Analysis of 17 available M77 strains (12 T28 and 5 T13) indicated that 2 (12%) were MLS resistant due to the ermA [TR] gene. Both MLS resistant strains were cultured from blood and belonged to T28 serotype. Multilocus sequence typing (MLST) showed that all M77 isolates belonged to sequence type 63. We conclude that 17 M77 GAS collected in the Netherlands in a 2-y period were associated with invasive disease and belonged to the same clonal complex. Since only 12% carried the ermA [TR] resistance gene, it is very likely that the gene has been acquired by horizontal transmission rather than from spread of a resistant circulating clone.
Insights
Group A Streptococcus (GAS) resistant to macrolide-lincosamide-streptogramin B antibiotics (MLS) is increasing. This study reports the first case of MLS-resistant GAS causing streptococcal toxic shock syndrome (STSS).
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Group A Streptococcus (GAS) resistance to macrolide-lincosamide-streptogramin B (MLS) antibiotics is rising in Europe.
- Streptococcal toxic shock syndrome (STSS) is a severe, life-threatening GAS infection.
- MLS resistance in GAS strains associated with STSS has not been previously documented.
Observation:
- A patient presented with STSS caused by an inducible MLS (iMLS) resistant T28 M77 Streptococcus pyogenes strain.
- The resistant strain carried the ermA [subclass TR] gene.
- A retrospective analysis identified M77 GAS strains, with 3.1% incidence over two years, and 12% of these M77 strains (specifically T28 serotype) exhibited MLS resistance due to the ermA [TR] gene.
Findings:
- All analyzed M77 isolates belonged to sequence type 63, indicating a common clonal origin.
- The MLS resistance gene (ermA [TR]) was found in 12% of the M77 strains examined.
- MLS-resistant strains were isolated from blood, suggesting association with invasive disease.
Implications:
- This is the first report of MLS-resistant GAS causing STSS.
- The findings suggest horizontal gene transfer of the ermA [TR] gene is more likely than the spread of a resistant clone.
- Continued surveillance is crucial to monitor the emergence and spread of antibiotic-resistant GAS strains, particularly those causing invasive infections like STSS.
Related Concept Videos
Streptococcal Pharyngitis
Staphylococcal Skin Infections
Diphtheria
Clinical Significance of Antibiotic Resistance
Bacterial Meningitis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
